Molecular Devices' Q3 Revenue Misses Guidance; Firm Offers Limp Outlook | GenomeWeb
NEW YORK (GenomeWeb News) — Molecular Devices’ third-quarter revenues edged up 1 percent while its net income dipped almost 40 percent year over year, the company said this week.
 
Revenues for the quarter ended Sept. 30 rose to $45.5 million from $45.2 million in the same quarter last year. In July the company said it expected to post between $48 million and $52 million in revenue.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.